Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

New treatments for androgenetic alopecia show promise but need more research for validation.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

A synthetic octapeptide may help promote hair growth and counteract hair loss.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Targeting LPA could help treat skin disorders.

Janus kinase inhibitors may help treat lichen planopilaris.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Upadacitinib may effectively treat resistant lichen planopilaris.

Stimulating sensory neurons can increase IGF-I production, which may help treat various diseases and improve tissue health.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Upadacitinib effectively treats pyoderma gangrenosum.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.